MedTrace Logo

Preoperative Biochemical Predictors of Outcome in Patients With Hip Fracture

NCT01280253 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 999

Last updated 2016-11-15

No results posted yet for this study

Summary

The objective of the study is to identify biochemical predictors of morbidity and mortality in patients suffering from hip fracture. For this purpose blood samples are collected prehospitally or in the emergency department in patients with a suspected hip fracture. During the hospital stay medical history, anesthesiological management recorded. In addition, american society of anesthesiology physiological score (ASA), revised cardiac risk index (RCRI), and POSSUM score is calculated. Morbidity and mortality is recorded " in house", after 30 days, after 4 months and after 1 year. Biochemical predictors of outcome will be evaluated with logistic regression analysis. Biochemical predictors include pro-brain natriuretic peptide, lactate, pro-calcitonin, adrenomedullin, copeptin, cystatin c. The predictive value of the potential markers will be compared to that of ASA, RCRI and POSSUM.

Conditions

  • Hip Fracture

Sponsors & Collaborators

  • Anna and Edwin Berger Foundation

    collaborator OTHER

  • Region Skane

    lead OTHER

Principal Investigators

  • Peter Bentzer, MD, PhD · Skane University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2014-08-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01280253 on ClinicalTrials.gov